Relapse to drug abuse following abstinence is a significant impediment in the treatment of cocaine dependence. Although various factors (stress, conditioned cues, drugs) that contribute to relapse have been studied in males, the impact in females has been less explored. We have recently shown sex differences for conditioned cue-induced and drug-primed reinstatement of cocaine-seeking in an animal model of relapse. Moreover, the differences seen in females are closely linked to the estrus phase of the estrous cycle. Building on these previous studies, this SCOR project will provide a comprehensive approach to examine sex and estrous cycle dependent differences in reinstatement of cocaine-seeking produced by various trigger factors. Using direct pharmacological activation of the neural pathways that mediate stress responses (e.g., ascending noradrenergic pathways and corticotropin-releasing factor receptors) we predict that female rats (particularly during the estrus phase) will show greater reinstatement of cocaine-seeking than male rats exposed to the same stressor. The use of the exact same stressors and cue reactivity approaches in both the animal model and the human clinical laboratory (SCOR Project #2),will provide a high degree of homology and integration. Following characterization of stress and stress+cue induced reinstatement in males and females, we will examine sex and estrous cycle dependent pharmacotherapy interventions that will attenuate relapse, specifically: a) clonidine, a noradrenergic receptor agonist that may selectively block stress-induced reinstatement;b) progesterone, an ovarian hormone that we have recently found to be inversely related to cocaine-seeking in females;and c) aripiprazole, a novel dopamine receptor partial agonist that blocks cue and drug-primed reinstatement in males, but has never been tested in females. The information gained from these studies will integrate with the clinical SCOR projects that will focus on gender differences and relapse in cocaine (Project #2) and nicotine (Project #4) dependent women andmen, including the relationship of ovarian hormones to drug-seeking. In addition, this project will parallel the preclinical animal model of sex and estrous cycle dependent differences in nicotine-seeking and reinstatement in Project #3. This preclinical animal model of relapse will characterize fundamental sex and estrous cycle dependent differences in cocaine-seeking behavior produced by known risk factors for relapse in humans (i.e., stress, cues, drugs). Furthermore, we will assess pharmacotherapies that may be generalized across males and females, as well as interventions that may be gender-specific. The results from these studies will help identify promising pharmacotherapeutic agents for future testing in the human laboratory setting.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA016511-09
Application #
8106255
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
9
Fiscal Year
2010
Total Cost
$178,215
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Moran-Santa Maria, Megan M; Sherman, Brian J; Brady, Kathleen T et al. (2018) Impact of endogenous progesterone on reactivity to yohimbine and cocaine cues in cocaine-dependent women. Pharmacol Biochem Behav 165:63-69
Kohtz, Amy S; Lin, Belle; Smith, Michael E et al. (2018) Attenuated cocaine-seeking after oxytocin administration in male and female rats. Psychopharmacology (Berl) 235:2051-2063
Moran-Santa Maria, Megan M; Vanderweyen, Davy C; Camp, Christopher C et al. (2018) Network Analysis of Intrinsic Functional Brain Connectivity in Male and Female Adult Smokers: A Preliminary Study. Nicotine Tob Res 20:810-818
Sherman, Brian J; Baker, Nathaniel L; Squeglia, Lindsay M et al. (2018) Approach bias modification for cannabis use disorder: A proof-of-principle study. J Subst Abuse Treat 87:16-22
Tomko, Rachel L; Saladin, Michael E; Baker, Nathaniel L et al. (2018) Sex Differences in Subjective and Behavioral Responses to Stressful and Smoking Cues Presented in the Natural Environment of Smokers. Nicotine Tob Res :
Moreland, Angela D; McRae-Clark, Aimee (2018) Parenting outcomes of parenting interventions in integrated substance-use treatment programs: A systematic review. J Subst Abuse Treat 89:52-59
Spencer, Sade; Neuhofer, Daniela; Chioma, Vivian C et al. (2018) A Model of ?9-Tetrahydrocannabinol Self-administration and Reinstatement That Alters Synaptic Plasticity in Nucleus Accumbens. Biol Psychiatry 84:601-610
Cox, Brittney M; Bentzley, Brandon S; Regen-Tuero, Helaina et al. (2017) Oxytocin Acts in Nucleus Accumbens to Attenuate Methamphetamine Seeking and Demand. Biol Psychiatry 81:949-958
Melis, Miriam; Frau, Roberto; Kalivas, Peter W et al. (2017) New vistas on cannabis use disorder. Neuropharmacology 124:62-72
Leong, Kah-Chung; Freeman, Linnea R; Berini, Carole R et al. (2017) Oxytocin Reduces Cocaine Cued Fos Activation in a Regionally Specific Manner. Int J Neuropsychopharmacol 20:844-854

Showing the most recent 10 out of 106 publications